Joshua F Lee1, Zachary Barrett-O'Keefe2, Ryan S Garten1, Ashley D Nelson3, John J Ryan4, Jose N Nativi4, Russell S Richardson5, D Walter Wray5. 1. Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA Geriatric Research, Education, and Clinical Center, VA Medical Center, Salt Lake City, Utah, USA. 2. Geriatric Research, Education, and Clinical Center, VA Medical Center, Salt Lake City, Utah, USA Department of Exercise & Sport Science, University of Utah, Salt Lake City, Utah, USA. 3. Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. 4. Division of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, Utah, USA. 5. Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA Geriatric Research, Education, and Clinical Center, VA Medical Center, Salt Lake City, Utah, USA Department of Exercise & Sport Science, University of Utah, Salt Lake City, Utah, USA.
Abstract
OBJECTIVE: While vascular dysfunction is well defined in patients with heart failure (HF) with reduced ejection fraction (HFrEF), disease-related alterations in the peripheral vasculature of patients with HF with preserved ejection fraction (HFpEF) are not well characterised. Thus, we sought to test the hypothesis that patients with HFpEF would demonstrate reduced vascular function, at the conduit artery and microvascular levels, compared with controls. METHODS: We examined conduit artery function via brachial artery flow-mediated dilation (FMD) and microvascular function via reactive hyperaemia (RH) following 5 min of ischaemia in 24 patients with Class II-IV HFpEF and 24 healthy controls matched for age, sex and brachial artery diameter. RESULTS: FMD was reduced in patients with HFpEF compared with controls (HFpEF: 3.1±0.7%; CONTROLS: 5.1±0.5%, p=0.03). However, shear rate at time of peak brachial artery dilation was lower in patients with HFpEF compared with controls (HFpEF: 42 070±4018/s; CONTROLS: 69 018±9509/s, p=0.01), and when brachial artery FMD was normalised for the shear stimulus, cumulative area-under-the-curve (AUC) at peak dilation, the between-group differences were eliminated (HFpEF: 0.11±0.03%/AUC; CONTROLS: 0.09±0.01%/AUC, p=0.58). RH, assessed as AUC, was lower in patients with HFpEF (HFpEF: 454±35 mL; CONTROLS: 660±63 mL, p<0.01). CONCLUSIONS: Collectively, these data suggest that maladaptations at the microvascular level contribute to the pathophysiology of HFpEF, while conduit artery vascular function is not diminished beyond that which occurs with healthy aging. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE: While vascular dysfunction is well defined in patients with heart failure (HF) with reduced ejection fraction (HFrEF), disease-related alterations in the peripheral vasculature of patients with HF with preserved ejection fraction (HFpEF) are not well characterised. Thus, we sought to test the hypothesis that patients with HFpEF would demonstrate reduced vascular function, at the conduit artery and microvascular levels, compared with controls. METHODS: We examined conduit artery function via brachial artery flow-mediated dilation (FMD) and microvascular function via reactive hyperaemia (RH) following 5 min of ischaemia in 24 patients with Class II-IV HFpEF and 24 healthy controls matched for age, sex and brachial artery diameter. RESULTS:FMD was reduced in patients with HFpEF compared with controls (HFpEF: 3.1±0.7%; CONTROLS: 5.1±0.5%, p=0.03). However, shear rate at time of peak brachial artery dilation was lower in patients with HFpEF compared with controls (HFpEF: 42 070±4018/s; CONTROLS: 69 018±9509/s, p=0.01), and when brachial artery FMD was normalised for the shear stimulus, cumulative area-under-the-curve (AUC) at peak dilation, the between-group differences were eliminated (HFpEF: 0.11±0.03%/AUC; CONTROLS: 0.09±0.01%/AUC, p=0.58). RH, assessed as AUC, was lower in patients with HFpEF (HFpEF: 454±35 mL; CONTROLS: 660±63 mL, p<0.01). CONCLUSIONS: Collectively, these data suggest that maladaptations at the microvascular level contribute to the pathophysiology of HFpEF, while conduit artery vascular function is not diminished beyond that which occurs with healthy aging. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: José R de Berrazueta; Armando Guerra-Ruiz; María Teresa García-Unzueta; Gema Martín Toca; Rocío Sainz Laso; María Sáez de Adana; Miguel A Casanova Martín; Manuel Cobo; Javier Llorca Journal: Eur J Heart Fail Date: 2010-03-30 Impact factor: 15.534
Authors: Bishnu P Dhakal; Rajeev Malhotra; Ryan M Murphy; Paul P Pappagianopoulos; Aaron L Baggish; Rory B Weiner; Nicholas E Houstis; Aaron S Eisman; Stacyann S Hough; Gregory D Lewis Journal: Circ Heart Fail Date: 2014-10-24 Impact factor: 8.790
Authors: Barry A Borlaug; Thomas P Olson; Carolyn S P Lam; Kelly S Flood; Amir Lerman; Bruce D Johnson; Margaret M Redfield Journal: J Am Coll Cardiol Date: 2010-09-07 Impact factor: 24.094
Authors: R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: Francesca Bursi; Susan A Weston; Margaret M Redfield; Steven J Jacobsen; Serguei Pakhomov; Vuyisile T Nkomo; Ryan A Meverden; Véronique L Roger Journal: JAMA Date: 2006-11-08 Impact factor: 56.272
Authors: Melissa A H Witman; Anette S Fjeldstad; John McDaniel; Stephen J Ives; Jia Zhao; Zachary Barrett-O'Keefe; Jose N Nativi; Josef Stehlik; D Walter Wray; Russell S Richardson Journal: Hypertension Date: 2012-07-02 Impact factor: 10.190
Authors: Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren Journal: Lancet Date: 2003-09-06 Impact factor: 79.321
Authors: Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska Journal: N Engl J Med Date: 2008-11-11 Impact factor: 91.245
Authors: Payman Zamani; Benjamin French; Jeffrey A Brandimarto; Paschalis-Thomas Doulias; Ali Javaheri; Julio A Chirinos; Kenneth B Margulies; Raymond R Townsend; Nancy K Sweitzer; James C Fang; Harry Ischiropoulos; Thomas P Cappola Journal: Am J Cardiol Date: 2016-09-15 Impact factor: 2.778
Authors: Wesley J Tucker; Michael D Nelson; Rhys I Beaudry; Martin Halle; Satyam Sarma; Dalane W Kitzman; Andre La Gerche; Mark J Haykowksy Journal: Card Fail Rev Date: 2016-11
Authors: Stephen M Ratchford; Heather L Clifton; D Taylor La Salle; Ryan M Broxterman; Joshua F Lee; John J Ryan; Paul N Hopkins; Josephine B Wright; Joel D Trinity; Russell S Richardson; D Walter Wray Journal: J Appl Physiol (1985) Date: 2020-09-17
Authors: G P T Areas; A Mazzuco; F R Caruso; R B Jaenisch; R Cabiddu; S A Phillips; R Arena; A Borghi-Silva Journal: Heart Fail Rev Date: 2019-01 Impact factor: 4.214